Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Adler

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Immunology and Cell Biology|January 9, 2013
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansionMarie-Clare St Rose, Roslyn A Taylor, Suman Bandyopadhyay, et al.
Journal for Immunotherapy of Cancer|November 29, 2019
IL-17 inhibits CXCL9/10-mediated recruitment of CD8<sup>+</sup> cytotoxic T cells and regulatory T cells to colorectal tumorsJu Chen, Xiaoyang Ye, Elise Pitmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cellsMarie-Clare St Rose, Harry Z Qui, Suman Bandyopadhyay, et al.
Cell Reports|May 3, 2019
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like MechanismCrystal Morales Del Valle, Joseph R Maxwell, Maria M Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsivenessSoo Mun Ngoi, Marie-Clare St Rose, Antoine M Menoret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulationSuman Bandyopadhyay, Meixiao Long, Harry Z Qui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2011
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiationHarry Z Qui, Adam T Hagymasi, Suman Bandyopadhyay, et al.
Oncogene|January 22, 2020
GRK2 enforces androgen receptor dependence in the prostate and prostate tumorsAdam J Adler, Payal Mittal, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2018
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T CellsPayal Mittal, Rebecca Abblett, Joseph M Ryan, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|October 20, 2007
Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigenMeixiao Long, Aaron M Slaiby, Shuang Wu, et al.
Immunology and Cell Biology|January 9, 2013
CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansionMarie-Clare St Rose, Roslyn A Taylor, Suman Bandyopadhyay, et al.
Journal for Immunotherapy of Cancer|November 29, 2019
IL-17 inhibits CXCL9/10-mediated recruitment of CD8<sup>+</sup> cytotoxic T cells and regulatory T cells to colorectal tumorsJu Chen, Xiaoyang Ye, Elise Pitmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2009
The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cellsMarie-Clare St Rose, Harry Z Qui, Suman Bandyopadhyay, et al.
Cell Reports|May 3, 2019
Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like MechanismCrystal Morales Del Valle, Joseph R Maxwell, Maria M Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2012
Presensitizing with a Toll-like receptor 3 ligand impairs CD8 T-cell effector differentiation and IL-33 responsivenessSoo Mun Ngoi, Marie-Clare St Rose, Antoine M Menoret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulationSuman Bandyopadhyay, Meixiao Long, Harry Z Qui, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2011
CD134 plus CD137 dual costimulation induces Eomesodermin in CD4 T cells to program cytotoxic Th1 differentiationHarry Z Qui, Adam T Hagymasi, Suman Bandyopadhyay, et al.
Oncogene|January 22, 2020
GRK2 enforces androgen receptor dependence in the prostate and prostate tumorsAdam J Adler, Payal Mittal, Adam T Hagymasi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2018
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T CellsPayal Mittal, Rebecca Abblett, Joseph M Ryan, et al.
Pageof 6